SC 13G/A | 2020-02-14 | Partner Fund Management, L.P. | Spark Therapeutics, Inc. | - | 0.0% | EDGAR |
SC 13D/A | 2019-10-29 | Children's Hospital of Philadelphia Foundation | Spark Therapeutics, Inc. | 1,629,932 | 4.2% | EDGAR |
SC 13G/A | 2019-05-06 | JPMORGAN CHASE & CO | Spark Therapeutics, Inc. | 855,908 | 2.2% | EDGAR |
SC 13G/A | 2019-04-10 | FMR LLC | Spark Therapeutics, Inc. | 210,339 | 0.6% | EDGAR |
SC 13G/A | 2019-03-11 | WELLINGTON MANAGEMENT GROUP LLP | Spark Therapeutics, Inc. | 204,092 | 0.5% | EDGAR |
SC 13D/A | 2019-03-07 | Children's Hospital of Philadelphia Foundation | Spark Therapeutics, Inc. | 1,992,160 | 5.2% | EDGAR |
SC 13G/A | 2019-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Spark Therapeutics, Inc. | 1,970,766 | 5.2% | EDGAR |
SC 13G/A | 2019-02-14 | Partner Fund Management, L.P. | Spark Therapeutics, Inc. | - | 5.8% | EDGAR |
SC 13G/A | 2019-02-13 | FMR LLC | Spark Therapeutics, Inc. | 3,891,577 | 10.3% | EDGAR |
SC 13G/A | 2019-02-12 | WELLINGTON MANAGEMENT GROUP LLP | Spark Therapeutics, Inc. | 2,835,671 | 7.5% | EDGAR |
SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | Spark Therapeutics, Inc. | 2,917,324 | 7.7% | EDGAR |
SC 13G/A | 2019-02-06 | BlackRock Inc. | Spark Therapeutics, Inc. | 3,106,298 | 8.2% | EDGAR |
SC 13G/A | 2019-01-28 | JPMORGAN CHASE & CO | Spark Therapeutics, Inc. | 2,442,909 | 6.4% | EDGAR |
SC 13G | 2018-12-28 | Partner Fund Management, L.P. | Spark Therapeutics, Inc. | - | 5.8% | EDGAR |
SC 13G/A | 2018-11-13 | PRICE T ROWE ASSOCIATES INC /MD/ | Spark Therapeutics, Inc. | 2,093,951 | 5.5% | EDGAR |
SC 13G/A | 2018-04-10 | WELLINGTON MANAGEMENT GROUP LLP | Spark Therapeutics, Inc. | 3,780,420 | 10.2% | EDGAR |
SC 13D/A | 2018-03-09 | Children's Hospital of Philadelphia Foundation | Spark Therapeutics, Inc. | 3,982,859 | 10.7% | EDGAR |
SC 13G/A | 2018-03-09 | FEDERATED INVESTORS INC /PA/ | Spark Therapeutics, Inc. | 1,497,788 | 4.0% | EDGAR |
SC 13G/A | 2018-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Spark Therapeutics, Inc. | 4,126,961 | 11.1% | EDGAR |
SC 13G | 2018-02-14 | FEDERATED INVESTORS INC /PA/ | Spark Therapeutics, Inc. | 1,851,400 | 5.0% | EDGAR |